Having trouble accessing articles? Reset your cache.

Forward movement on drug pricing bill, enactment uncertain

Chairs of the Republican-controlled Senate Health Committee and the Democratic-controlled House Energy & Commerce Committee have agreed to support the Lower Health Care Costs Act of 2019 (S. 1895), giving the bill added momentum amid a packed agenda in Congress.

The bill seeks to squeeze PBM profits out of the drug supply chain, eliminate tactics branded drug manufacturers use to block generic and biosimilar

Read the full 634 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE